Company Profile

Thyrocare Technologies has completed the acquisition by way purchase of 100% equity shares in Think Health Diagnostic (Think Health) from all the existing shareholders of Think Health on February 27, 2024 and consequently Think Health has become wholly-owned subsidiary company of Thyrocare with effective from February 27, 2024.

Thyrocare Technologies is India's first and most advanced Totally Automated Laboratory having its strong presence in several cities / towns in India and internationally. Thyrocare is India's first fully automated diagnostic laboratory with a focus on providing quality at affordable costs to laboratories and hospitals in India and other countries.

Thyrocare Technologies is currently trading at Rs. 717.15, up by 75.35 points or 11.74% from its previous closing of Rs. 641.80 on the BSE.

The scrip opened at Rs. 646.00 and has touched a high and low of Rs. 722.00 and Rs. 643.00 respectively. So far 25223 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 722.00 on 28-Jan-2024 and a 52 week low of Rs. 416.00 on 29-Mar-2023.

Last one week high and low of the scrip stood at Rs. 722.00 and Rs. 601.10 respectively. The current market cap of the company is Rs. 3447.22 crore.

The promoters holding in the company stood at 71.11%, while Institutions and Non-Institutions held 17.24% and 11.65% respectively.

Thyrocare Technologies has completed the acquisition by way purchase of 100% equity shares in Think Health Diagnostic (Think Health) from all the existing shareholders of Think Health on February 27, 2024 and consequently Think Health has become wholly-owned subsidiary company of Thyrocare with effective from February 27, 2024.

Thyrocare Technologies is India's first and most advanced Totally Automated Laboratory having its strong presence in several cities / towns in India and internationally. Thyrocare is India's first fully automated diagnostic laboratory with a focus on providing quality at affordable costs to laboratories and hospitals in India and other countries.

Torrent Power has emerged as the Successful Bidder and has received Letter of Intent from PFC Consulting on February 27, 2024 for Establishment of Inter-state transmission scheme ‘Transmission System for Evacuation of Power from RE Projects in Solapur (1,500 MW) SEZ in Maharashtra’ under Tariff Based Competitive Bidding (TBCB) Process.

Infosys has launched its Responsible AI Suite, a part of Infosys Topaz, an AI-first set of services, solutions and platforms using generative AI. The rise of powerful generative AI systems in the past year has raised several concerns and conversations around the ethical dimensions of AI. According to the Infosys Generative AI Radar, by Infosys Knowledge Institute, enterprises worldwide are identifying data privacy, security, ethics, and bias as the primary challenges in their pursuit of innovation with AI. The Responsible AI Suite is designed to help enterprises balance innovation with ethical considerations, such bias and privacy prevention, and maximize their return on investments.

UGRO Capital has raised Rs 200 crore through the allotment of 20,00,000 Secured, Rated, Listed, Redeemable, Non-Convertible Debentures (NCDs) having face value of Rs 1,000 each at par through public issue. The Investment and Borrowing Committee of the Board of Directors of the Company (Committee) on February 27, 2024 has inter alia made an allotment of the same. 

Hindustan Zinc has incorporated a wholly owned subsidiary (WOS) of the Company in the name of ‘Hindmetal Exploration Services’. The said WOS has been incorporated with object to explore, discover, develop and tap mineral resources including strategic minerals, deep-seated minerals and offshore minerals through systematic exploration of all types of mineral deposits and to participate in the auctioning of mining blocks containing critical minerals.

Titan Company is all set to purchase balance 1,19,489 equity shares held by the individual shareholders of CaratLane Trading (CaratLane) representing 0.36% of the total paid-up equity share capital of face value of Rs 2 each of CaratLane. The purchase transaction would be completed on fulfilment of other closing conditions. The Company currently holds 99.64% of the total equity share capital of CaratLane. The proposed purchase of shares would further increase the Company’s stake in CaratLane to 100%, thereby making CaratLane a Wholly Owned Subsidiary of the Company. The indicative time period for completion of the transaction would be March 31, 2024.

Thyrocare Technologies has completed the acquisition by way purchase of 100% equity shares from all the existing shareholders of Think Health Diagnostic on February 27, 2024 and consequently Think Health has become wholly-owned subsidiary company of Thyrocare with effect from February 27, 2024.

Bn Holdings has incorporated a wholly owned subsidiary (WOS) in London, England. This WOS is a private company limited by shares and named as ‘BN Holdings Europe’. The said WOS has been incorporated with an object of Manufacture of other food products n.e.c, Other manufacturing n.e.c., Manufacture of oils and fats, Wholesale of dairy products, eggs and edible oils and fats.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Thyrocare Technologies has informed that, Nitin Chugh has been appointed as Chief Commercial Officer of the Company, being part of the Senior Management of the Company with effect from February 22, 2024. Further, the details/disclosures required under Regulation 30 of the SEBI Listing Regulations, read the SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, are enclosed as Annexure -A.

The above information is a part of company’s filings submitted to BSE.

Thyrocare Technologies has entered into a Share Purchase Agreement with Think Health Diagnostic (Think Health) and their existing shareholders on February 1, 2024 to acquire 100% stake in Think Health by way purchase of equity shares from all the existing shareholders of Think Health. With this acquisition, the Company aims to enter into a new line of business of offering ECG testing services at home.

Thyrocare Technologies is India's first and most advanced Totally Automated Laboratory having its strong presence in several cities / towns in India and internationally. Thyrocare is India's first fully automated diagnostic laboratory with a focus on providing quality at affordable costs to laboratories and hospitals in India and other countries.